430 related articles for article (PubMed ID: 28823497)
21. Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting.
Sistigu A; Di Modugno F; Manic G; Nisticò P
Cytokine Growth Factor Rev; 2017 Aug; 36():67-77. PubMed ID: 28595838
[TBL] [Abstract][Full Text] [Related]
22. Exploring the Crosstalk between Inflammation and Epithelial-Mesenchymal Transition in Cancer.
Chattopadhyay I; Ambati R; Gundamaraju R
Mediators Inflamm; 2021; 2021():9918379. PubMed ID: 34220337
[TBL] [Abstract][Full Text] [Related]
23. Mitochondria driven innate immune signaling and inflammation in cancer growth, immune evasion, and therapeutic resistance.
Pandey S; Anang V; Schumacher MM
Int Rev Cell Mol Biol; 2024; 386():223-247. PubMed ID: 38782500
[TBL] [Abstract][Full Text] [Related]
24. Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment.
Atretkhany KN; Drutskaya MS; Nedospasov SA; Grivennikov SI; Kuprash DV
Pharmacol Ther; 2016 Dec; 168():98-112. PubMed ID: 27613100
[TBL] [Abstract][Full Text] [Related]
25. Relationship between epithelial-to-mesenchymal transition and the inflammatory microenvironment of hepatocellular carcinoma.
Yan L; Xu F; Dai CL
J Exp Clin Cancer Res; 2018 Aug; 37(1):203. PubMed ID: 30157906
[TBL] [Abstract][Full Text] [Related]
26. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
27. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
Front Immunol; 2019; 10():757. PubMed ID: 31031757
[TBL] [Abstract][Full Text] [Related]
28. EMT and inflammation: inseparable actors of cancer progression.
Suarez-Carmona M; Lesage J; Cataldo D; Gilles C
Mol Oncol; 2017 Jul; 11(7):805-823. PubMed ID: 28599100
[TBL] [Abstract][Full Text] [Related]
29. TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation.
Yoshimatsu Y; Wakabayashi I; Kimuro S; Takahashi N; Takahashi K; Kobayashi M; Maishi N; Podyma-Inoue KA; Hida K; Miyazono K; Watabe T
Cancer Sci; 2020 Jul; 111(7):2385-2399. PubMed ID: 32385953
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression.
Yang L; Lin PC
Semin Cancer Biol; 2017 Dec; 47():185-195. PubMed ID: 28782608
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanism involved in epithelial to mesenchymal transition.
Jayachandran J; Srinivasan H; Mani KP
Arch Biochem Biophys; 2021 Oct; 710():108984. PubMed ID: 34252392
[TBL] [Abstract][Full Text] [Related]
32. Icariside II inhibits the EMT of NSCLC cells in inflammatory microenvironment via down-regulation of Akt/NF-κB signaling pathway.
Song J; Feng L; Zhong R; Xia Z; Zhang L; Cui L; Yan H; Jia X; Zhang Z
Mol Carcinog; 2017 Jan; 56(1):36-48. PubMed ID: 26859114
[TBL] [Abstract][Full Text] [Related]
33. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
Qu X; Tang Y; Hua S
Front Immunol; 2018; 9():563. PubMed ID: 29662489
[TBL] [Abstract][Full Text] [Related]
34. Eph Receptors: Actors in Tumor Microenvironment.
Zhou X; Tu P; Chen X; Guo S; Wang J
Crit Rev Oncog; 2017; 22(5-6):499-505. PubMed ID: 29604927
[TBL] [Abstract][Full Text] [Related]
35. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
36. Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
Puré E; Lo A
Cancer Immunol Res; 2016 Apr; 4(4):269-78. PubMed ID: 27036971
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-induced epithelial to mesenchymal transition in cancer.
Hapke RY; Haake SM
Cancer Lett; 2020 Sep; 487():10-20. PubMed ID: 32470488
[TBL] [Abstract][Full Text] [Related]
38. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
39. The bad seed: Cancer stem cells in tumor development and resistance.
Koren E; Fuchs Y
Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
[TBL] [Abstract][Full Text] [Related]
40. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis.
Baj J; Brzozowska K; Forma A; Maani A; Sitarz E; Portincasa P
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
